Stock listing
SBTX Stock Price, News, Filings & Events — Skinbiotherapeutics Plc
Selected listing: SBTX · LSE · GBX · GB
This page tracks Skinbiotherapeutics Plc's SBTX:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SBTX:LSE. SBTX:LSE is the stock-level entry point for investors researching Skinbiotherapeutics Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Skinbiotherapeutics Plc (SBTX) is a public company based in the UK, focusing on developing skin health products through innovative biotechnology. The company has a market capitalization of approximately £34 million. Skinbiotherapeutics aims to leverage its expertise in skin biotherapeutics to create effective solutions for various skin conditions.
- Ticker
- SBTX:LSE
- Asset type
- Stock
- Market cap
- $33.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- LSE
- Currency
- GBX
Skinbiotherapeutics Plc SBTX:LSE stock context
This page tracks Skinbiotherapeutics Plc's SBTX:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SBTX:LSE. SBTX:LSE is the stock-level entry point for investors researching Skinbiotherapeutics Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Skinbiotherapeutics Plc (SBTX) is a public company based in the UK, focusing on developing skin health products through innovative biotechnology. The company has a market capitalization of approximately £34 million. Skinbiotherapeutics aims to leverage its expertise in skin biotherapeutics to create effective solutions for various skin conditions.
Latest news from Skinbiotherapeutics Plc
Skinbiotherapeutics Plc earnings calls
SKINBIOTHERAPEUTICS PLC (SBTX) — Investor Presentation
June 29, 2026 · Replay with transcript and chapters
SKINBIOTHERAPEUTICS PLC (SBTX) — Superdrug Commercial Agreement
July 3, 2025 · Replay with transcript and chapters
SKINBIOTHERAPEUTICS PLC (SBTX) — Half Year results for the six months ended 31 December 2024 & Launch
April 16, 2025 · Replay with transcript and chapters
SKINBIOTHERAPEUTICS PLC (SBTX) — Full Year Results
December 10, 2024 · Replay with transcript and chapters
SKINBIOTHERAPEUTICS PLC (SBTX) — Investor Presentation
July 29, 2024 · Replay with transcript and chapters
SKINBIOTHERAPEUTICS PLC (SBTX) — Interim Results
March 22, 2024 · Replay with transcript and chapters
Research Skinbiotherapeutics Plc
Skinbiotherapeutics Plc investor report
Review AI stock analysis and investor report context for SBTX:LSE.
Skinbiotherapeutics Plc company profile
View the public company page for Skinbiotherapeutics Plc on 6ix.
Skinbiotherapeutics Plc news
Read company news and market updates connected to Skinbiotherapeutics Plc.
Skinbiotherapeutics Plc investor events
Find investor webinars, events, and replay context for Skinbiotherapeutics Plc.